Several possible studies
Story checked
Novo Nordisk Foundation funds genomic research into metabolic diseases (opens in a new tab)
news-medical.net · 2026-09-30
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Novo Nordisk Foundation funds genomic research into metabolic diseases
news-medical.net · 2026-09-30
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedThe Novo Nordisk Foundation has committed $53 million to renew and expand the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Broad Institute.View evidenceHide evidence
As stated$53 million
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedThe funding will scale up the Center's transatlantic efforts to decode the biological drivers of type 2 diabetes and obesity and identify new targets for potential therapies by combining massive-scale data generation, artificial intelligence, and advanced cellular models.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedThe Center says thousands of genetic variants have been linked to diabetes and obesity, but understanding the biology has remained a major challenge.View evidenceHide evidence
As statedthousands of genetic variants
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedOver the next five years, researchers will aim to create hundreds of millions of detailed cell profiles, including from fat cells and brain cells grown from stem cells, and use the dataset to train specialized AI programs that predict how DNA changes disrupt cellular health.View evidenceHide evidence
As statedhundreds of millions of detailed cell profiles
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedThe Center's efforts have helped underscore that diabetes and obesity are not single conditions, but can each be broken down into distinct genetic subtypes.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Splicing across adipocyte differentiation is highly dynamic and impacted by metabolic phenotype.
Research Square · 2023 · PubMed
Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · 2010 · Crossref
Bridging the variant-to-function gap in type 2 diabetes: advances and challenges.
2026 · Europe PMC
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · 2020 · Crossref
Variant-to-function approaches for adipose tissue: Insights into cardiometabolic disorders.
Cell Genomics · 2025 · Europe PMC, Crossref
And 10 more candidates considered.